Navigation Links
ZONARE Medical Systems Announces Appointment of PJ Ryland as Vice President of Business Development & Corporate Accounts

MOUNTAIN VIEW, Calif., Oct. 28, 2011 /PRNewswire/ -- ZONARE Medical Systems, Inc., a developer of high-end ultrasound solutions, announced the recent promotion of PJ Ryland to Vice President of Business Development & Corporate Accounts.  A 25-year veteran of the ultrasound industry, Ryland has been with ZONARE since 2005.

In addition to managing key accounts and strategic partners, Ryland will lead ZONARE's U.S. based clinical applications group. Previously Ryland served as National Accounts Manager, where she managed and grew key relationships with Broadlane/MedAssets, Department of Defense, VA, HealthTrust Purchasing Group, St. Jude Medical, Sutter Health and Kaiser Permanente, where ZONARE just won a new 3-year contract. Prior to joining ZONARE, she was with Siemens Medical Solutions' Ultrasound Division and Acuson for 20 years, where she held various positions in sales and national accounts. Ryland started her career in the clinical environment at University of Texas Health Science Center in Houston.

"With her extensive ultrasound industry expertise, PJ has been instrumental in building and maintaining relationships with major health systems and strategic partners," said Tim Marcotte, Chief Operating Officer and Chief Financial Officer, ZONARE Medical Systems.  "I strongly believe her success is a direct result of her commitment to ultrasound and customer loyalty that echoes ZONARE's focus of delivering meaningful technologies that improve workflow and deliver unprecedented image quality to enable clinicians to deliver a more reliable and confident diagnosis for the patient."

"PJ has the ability to anticipate customers' current and future needs and work with the development and engineering teams to develop solutions," said Glen W. McLaughlin, Ph.D., Vice President and Chief Technology Officer, ZONARE Medical Systems.  "Since ZONARE introduced its groundbreaking Zone Sonography Technology more than 12 years ago, we have continually invested to expand the value and versatility of the system with high quality ultrasound solutions that deliver premium performance across a variety of clinical applications."

About the Ultrasound Platform

ZONARE's ultrasound system delivers high-end image quality powered by its proprietary Zone Sonography™ Technology (ZST). The system's innovative, software-based design and architecture allows continuous performance enhancements and upgrades via software and delivers the highest level of system uptime and customer productivity.  The Ultrasound platform delivers premium performance and provides mobility and workflow advantages across a wide range of clinical settings.

About ZONARE Medical Systems, Inc.

ZONARE Medical Systems, Inc., based in Mountain View, Calif, is committed to ultrasound excellence through its innovative, software-based, next generation technology, and putting customers and employees first. The patented design and architecture of the Ultrasound platform deliver high-end image quality and clinical versatility at unparalleled value.  ZONARE's exclusive ultrasound focus has resulting in achieving a user loyalty rating of 100 percent in the KLAS Top 20: 2009 Year-End Report.  All ZONARE customers interviewed for this ultrasound market report indicated that they would purchase a ultrasound system again. For more information, visit:

ZONARE,, and Zone Sonography is a trademark of ZONARE Medical Systems, Inc.

SOURCE ZONARE Medical Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Imaging Industry Executive Jay D. Miller Tapped to Lead ZONARE
2. ZONARE Ranks in Top 3 in KLAS 2010 Ultrasound Report
3. ZONARE Provides Ultrasound System for Medical Missions to Guatemala
4. ZONARE Scores in Clinical Applications, Performance and Customer Support & Service in KLAS 2011 Ultrasound Report
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. Globus Medical Raises $110 Million in Series E Financing Round
9. Quark Pharmaceuticals Appoints New Chief Medical Officer
10. Boston University Biomedical Engineers Find Chink in Bacterias Armor
11. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
Post Your Comments:
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical ... innovative solutions for injectable drug administration, today shared the ... ID Adapter for improving the intradermal administration of polio ... Skin Vaccination Summit in May 2017 by Dr. ... Polio Department, World Health Organization (WHO), and recently published ...
(Date:10/4/2017)... 2017 OBP Medical , a ... devices, today announced regulatory approval from ... Agência Nacional de Vigilância Sanitária (ANVISA)) to market ... retractor with integrated LED light source and smoke ... exposure of a tissue pocket or cavity during ...
(Date:10/2/2017)... 2017 The Rebound mobile app is poised to ... the tide of prescription drug addiction. The app empowers users ... and stepping down their dosage in a safe, controlled manner ... 2017; the first 100,000 people to sign up will enjoy ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 2017 , ... Ellevate Network, the leading network for professional women, brought together ... equality at their inaugural Summit in New York City in June. The event was ... of over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of ... Philippines. “The Journey: From the Mountains to the Mission Field” is the creation of ... taught all ages and currently teaches a class of ladies at her church, which ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the ... medical article to the newly revamped Cosmetic Town journal section, featuring ... transplant procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations ... literacy software tool, and the Cancer Patient Education Network (CPEN), an independent professional ... announce a new strategic alliance. , As CPEN’s strategic partner, HLI will ...
Breaking Medicine News(10 mins):